X
20
Samyang Holdings Corporation Gyeonggi-do Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Docetaxel, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2013-185 - Rev 01
This Chemical Type CEP, issued on August 12, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2593 associated with this CEP further emphasizes